Global Assisted Reproductive Technology Market is valued at USD 28.94 Billion in 2021 and is expected to reach USD 56.18 Billion by 2028 with a CAGR of 9.94% over the forecast period.
Increasing number of reproductive problems, rising awareness about infertility treatments are driving the growth of the Global Assisted Reproductive Technology Market.
Download Free Exclusive Sample (200 Pages PDF) Report @:
https://brandessenceresearch.com/requestSample/PostId/1836
Scope of Global Assisted Reproductive Technology Market:
ART (assisted reproductive technology), primarily an uncontrolled multi-billion dollar industry is the only type of medical treatment that has the “ultimate goal” of creating another person. Basic ART (assisted reproductive technology) involves dietary changes, lifestyle changes, and medication or hormone therapy, and approximately 85% of infertility cases are treated with these measures. Additionally, more sophisticated and invasive interventions include intrauterine insemination (IUI) and in vitro fertilization (IVF). Intrauterine insemination (IUI) is a relatively simple nonsurgical procedure in which sperm produced by a partner or donor is inserted into a woman’s uterus during her ovulatory phase and brought closer to the ovum. In vitro fertilization (IVF) is a more complicated procedure in which the ovum is removed from a woman’s body by laparoscopy, fertilized by her spouse’s or donor’s semen, incubated in a laboratory dish until the embryo develops, and then transferred to the woman’s uterus. Some couples may also need a gamete intrafallopian transfer or zygote intrafallopian transfer.
All but the most basic ART require treatment by a doctor, usually a reproductive endocrinologist or urologist. Additionally, intrauterine insemination (IUI) and in vitro fertilization (IVF) can also be used for surrogate pregnancies. The surrogate is a third party who conceives the baby for a full term, realizing that she will give the baby to the desired parent. In pregnancy surrogacy, the woman is conceived with the fertilized egg of the expected couple (using either the couple’s gametes or donor gametes); thus, the surrogate does not have a genetic relationship with the baby. In partial surrogacy, the woman is implanted with the intended father’s sperm (or donor’s sperm) for the purpose of fertilizing one of the surrogate’s own eggs; in this case, the surrogate is genetically related to the baby.
The Covid-19 has affected millions of people worldwide, resulting in high mortality rates. Local disease has had a negative impact on the auxiliary reproductive technology market due to mobility limitations and safety concerns during the process. Many organizations have undertaken initiatives to maintain reproductive health standards. The decrease in the number of ART procedures at the beginning of Covid-19 has affected the market growth.
Key Players of Global Assisted Reproductive Technology Market:
- Cook Medical Inc.
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Genea Biomedx, Merck KGaA (EMD Serono, Inc.)
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- The Cooper Companies, Inc. (CooperSurgical, Inc.)
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
- others
Global Assisted Reproductive Technology Market Segmentation:
By Product:
- Instrument (Sperm Separation System, Cryptosystem, Incubator, Imaging System, Ovum Aspiration Pump, Cabinet, Micromanipulator, Laser Systems, Others)
- Accessory & Disposable
- Reagents & Media (Cryopreservation Media, Semen Processing Media, Ovum Processing Media, Embryo Culture Media)
By Technology:
- In Vitro-Fertilization
- Artificial Insemination
- Others
By End-User:
- Fertility Clinic
- Hospital
- Surgical Center
- Clinical Research Institute
Get Methodology of the Assisted Reproductive Technology Market Report @:
https://brandessenceresearch.com/requestMethodology/PostId/1836
News: Silverfleet Capital Invested in Leading UK Fertility Group CARE Fertility
On August 24th, 2020; Silverfleet Capital, a Pan-European private equity firm, entered into a binding agreement with CARE Fertility Holdings Limited (CARE or Company) on April 25, 2019 to acquire a majority stake. Headquartered in Nottingham, England, the company is the UK’s leading breeding service provider with a strong scientific and clinical backbone. The terms of the transaction were not disclosed.
Monash IVF Group Ltd. Completed the Acquisition of Buderim, Queensland-based Fertility Services Provider Fertility Solutions
On September 16th, 2019; Monash, a Richmond-based Victoria-based healthcare facility, bought some property, liability, and fertility solutions contracts, with potential additional earnings payments for a period of four years running through June 30, 2023. Monash’s operations in Queensland will be expanded with the addition of two clinics, one in Sunshine Coast and one in Bundaberg.
GI Partners Completes Acquisition and Merger of California Cryobank and Cord Blood Registry
On August 6th, 2018; GI Partners completed the previously announced acquisition and merger of California Cryobank (CCB), the world’s leading donor sperm and egg bank and cord blood registry (CBR), the world’s largest stem cell collection and storage company. California CryoBank Life Sciences is a leading company in the stem cell storage and reproductive tissue services market.
Global Assisted Reproductive Technology Market Dynamics:
The growth of the global assisted reproductive technology market is largely driven by rising number of cases of infertility rates; increased funding from private and government agencies for infertility services; rising awareness about infertility treatment and surrogacy; and an increase in technology in auxiliary reproductive technology. According to the World Health Organization (WHO); by 2020, an estimated 186 million individuals and 48 million couples have been diagnosed with infertility. According to the Centers for Disease Control and Prevention (CDC), approximately six percent to 12 percent of U.S. women with PCOS were also diagnosed with infertility. The Brandessence report estimates that one in six American couples experiences infertility at some point and about 14 percent of married couples who have not been surgically sterilized experience infertility in any given year. More precisely, nine out of every 100 women worldwide between the ages of 20 and 44 cannot conceive. As Dave Shed states, “Because disability only has a neutral or negative effect on fertility, people with disabilities are just as likely as or more likely to experience infertility than people with disabilities. Thus, it is expected that at least fourteen percent of heterosexual couples trying to conceive, with at least one partner having a disability, are infertile in any year, and at least one-sixth of such couples will experience infertility at some point in their relationship. An estimated 7.3 million couples in the United States are currently experiencing infertility.
By 2025, that number is projected to rise to an estimated 7.7 million. For instance; in February 2021, TMRW Life Sciences, a life science technology company providing a platform for monitoring and tracking, announced the launch of the world’s first automated cryo sampling management solution for eggs and embryos used in In vitro fertilization (IVF) process. Thus, advances in technology, software, and imaging systems have been used to monitor fetal growth on monitors. Furthermore, in 2018, LUMSA University in Italy announced the WoMoGeS (Women’s Movement and Pregnancy Surrogacy) project, which aims to raise awareness about pregnancy surrogacy among vulnerable women in developing countries. Furthermore, the presence of emerging key players in auxiliary reproductive technology and the increase in disposable income drive the growth of the market.
However, the high value associated with the treatment and socio-ethical stigma regarding the procedures may limit the adoption of assisted reproductive technology in the global market. According to Brandessence, most women in emerging countries cannot afford infertility services due to their high costs.
In spite of that, a rise in demand for in-vitro fertilization for effective treatment, and high success rate acts may offer more growth opportunities for the further growth of the global assisted reproductive technology market.
Global Assisted Reproductive Technology Market Regional Analysis:
Europe is expected to capture the major share of the assisted reproductive technology market owing to the increasing prevalence of infertility with the high demand for ART procedures in this region. Spain, Denmark, the United Kingdom, Germany, and France are the most active breeding nations in Europe, and market growth is expected to continue. In Spain, for example, 140,909 ART treatment cycles are performed annually, according to the European Society of Human Reproduction and Embryology.
North America is the second dominant region in the assisted reproductive technology market owing to the increasing adoption of reproductive services in patients in the U.S.. In addition, increasing disposable income and the high utilization of technologically advanced services are driving the adoption of these services in the region during the forecast period.
On Special Requirement Assisted Reproductive Technology Market Report is also available for below Regions and Country:
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherland
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest Of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest Of MEA
Buy Now @
https://brandessenceresearch.com/Checkout?report_id=1836
This comprehensive report will provide:
- Enhance your strategic decision making
- Assist with your research, presentations, and business plans
- Show which emerging market opportunities to focus on
- Increase your industry knowledge
- Keep you up-to-date with crucial market developments
- Allow you to develop informed growth strategies
- Build your technical insight
- Illustrate trends to exploit
- Strengthen your analysis of competitors
- Provide risk analysis, helping you avoid the pitfalls other companies could make
- Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of the market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are the main factors responsible for new product launches?
- How big are the global & regional markets in terms of revenue, sales, and production?
- How far will the market grow in the forecast period in terms of revenue, sales, and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2028?
- Which region has more opportunities?
Key Benefits of Global Assisted Reproductive Technology Market Report:
- Global Assisted Reproductive Technology market report covers in-depth historical and forecast analysis.
- Global Assisted Reproductive Technology market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Assisted reproductive technology types, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Assisted Reproductive Technology market report helps to identify opportunities in the marketplace.
- Global Assisted Reproductive Technology market report covers an extensive analysis of emerging trends and competitive landscape.
Get Access to the Full Report Here:
https://brandessenceresearch.com/healthcare/assisted-reproductive-technology-market
Related Reports:
The Global Surgical Instrument Tracking Systems Market in terms of revenue was worth of USD 193.8 Million in 2021 and is Projected to reach USD 513.1 Million by 2028, growing at a CAGR of 14.92% from 2021 to 2027.
Animal Vaccine Market was worth of USD 11.13 billion in 2021 and it is expected to reach 20.48 billion by the end of 2028 with the CAGR of 9.1% during Forecast Period.
Hemophilia Gene Therapy Market is valued at USD 331.4 Million in 2021 and expected to reach USD 4092.6 Million by 2028 with a CAGR of 43.2% over the forecast period.
Global Bioinformatics Market in terms of revenue was worth of USD 10.82 Billion in 2021 and expected to reach USD 24.07 Billion by 2028, growing at a CAGR of 12.1% from 2021 to 2028.
Colorectal Cancer Market is valued at USD 11.83 Billion in 2021 and is expected to reach USD 16.21 Billion by 2028 with a CAGR of 5.40% over the forecast period.
Global Medical Tricorder Market is valued at USD 3425.4 Million in 2021 and is expected to reach USD 5411.2 Million by 2028 with a CAGR of 6.75% over the forecast period.
Global Healthcare CRM Market is valued at USD 12.53 Billion in 2021 and is expected to reach USD 31.54 Billion by 2028 with a CAGR of 14.1% over the forecast period.
The Global Metaverse in Healthcare Market is valued at USD 5056.4 Million in 2021 and is expected to reach USD 7453.6 Million by 2028 with a CAGR of 33.7% over the forecast period.
Global Demand For Advanced Wound Care Market, in terms of revenue, was estimated to be USD 9.01 billion in 2018 and is expected to reach USD 13.27 billion in 2025, growing at a CAGR of 5.85% from 2019 to 2025.
According to Brandessence Market Research latest research study says Global demand for biophotonics market size in terms of revenue, was worth of USD 53.28 Billion in 2020. The biophotonics market is likely to reach USD 109.23 Billion by 2027 end, growing at a robust 10.8% CAGR.
The Global Sterility Testing Market in terms of revenue was worth of USD 1036.13 Million in 2021 and expected to reach USD 2193.8 Million by 2028, growing at a CAGR of 12.6% from 2021 to 2028.
i-Factor: Live Market intelligence platform
I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic. Register for free trial here at https://brandessenceresearch.com/i-factor/login/userRegister
Brandessence Market Research & Consulting Pvt ltd.
Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact:
Mr. Vishal Sawant
Email: vishal@brandessenceresearch.com
Email: Sales@brandessenceresearch.com
Corporate Sales: +44-2038074155
Asia Office: +917447409162